George Yaghmour - Concepedia

Author

George Yaghmour

University of Southern California ORCID

Also Known As

G Yaghmour, G. Yaghmour, GEORGE YAGHMOUR, George Yaghmour

165

Publications

654

Citations

H-Index

Concepts

All Affiliations

University of Southern California University of Tennessee Health Science Center USC Norris Comprehensive Cancer Center Cleveland Clinic Dana-Farber Cancer Institute

About

George Yaghmour is an author at University of Southern California specializing in medicine, hematology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	166
2	Health Sciences	4	4	141
3	Blood Transplantation	1	1	12
4	Cell Biology	1	1	12
5	Cellular Therapies	1	1	12

George Yaghmour

Publications

403

Citations

H-Index

Page 1

	Year	Citations
Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemia Anjali S. Advani, Anna Moseley, Kristen M. O’Dwyer, Blood Advances Hematological MalignancyLymphoid NeoplasiaNovel Treatment StrategiesPh+ AllMedicine	2022	68
Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lung Brennan McCullar, Manjari Pandey, George Yaghmour, Breast Cancer Research and Treatment Tumor HeterogeneityGenomic LandscapeSmall Cell CarcinomaPathologyCancer Genomics	2016	46
Role of Genomic Instability in Immunotherapy with Checkpoint Inhibitors. George Yaghmour, Manjari Pandey, Catherine G. Ireland, PubMed	2016	29
Ibrutinib has some activity in Richter’s syndrome Smith Giri, Andrew W. Hahn, George Yaghmour, Blood Cancer Journal Clinical DisordersTranslational MedicineRichter ’Clinical Medicine	2015	26
Early mortality in acute myeloid leukemia Andrew W. Hahn, Smith Giri, George Yaghmour, Leukemia Research Hematological MalignancyMedicineAcute Myeloid LeukemiaMixed-phenotype Acute LeukemiaHematology	2015	25
Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL Gregory W. Roloff, Ibrahim Aldoss, Noam E. Kopmar, Journal of Clinical Oncology	2024	23
Genomic alterations in neuroendocrine cancers of the ovary George Yaghmour, Philippe Prouet, Eric Wiedower, Journal of Ovarian Research	2016	21
Combination chemotherapy plus dasatinib leads to comparable overall survival and relapse‐free survival rates as allogeneic hematopoietic stem cell transplantation in Philadelphia positive acute lymphoblastic leukemia Jeremy Chang, Dan Douer, Ibrahim Aldoss, Cancer Medicine	2019	19
The presence of Philadelphia chromosome does not confer poor prognosis in adult pre‐B acute lymphoblastic leukaemia in the tyrosine kinase inhibitor era – a surveillance, epidemiology, and end results database analysis Igwe J. Igwe, Dongyun Yang, Akil Merchant, British Journal of Haematology	2017	18
Ziftomenib Combined with Venetoclax/Azacitidine in Relapsed/Refractory <i>NPM1</i>-m or <i>KMT2A</i>-r Acute Myeloid Leukemia: Interim Phase 1a Results from KOMET-007 Amir T. Fathi, Ghayas C. Issa, Eunice S. Wang, Blood	2024	18

Page 1